Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Frederick Fitzke
Introduction
Frederick Fitzke is a notable inventor based in London, GB. He has made significant contributions to the field of biomedical research, particularly in the area of cell death markers. His work is essential for advancing our understanding of cellular processes, especially in the context of eye health.
Latest Patents
Frederick Fitzke holds a patent for a composition comprising a cell death marker and a wavelength-optimized label. This invention relates to the use of a cell death marker labeled with a wavelength-optimized label for identifying cell death in the eye. Suitable cell death markers include Annexins and their fragments and derivatives. The patent also covers a pharmaceutical composition that utilizes this cell death marker and a method for monitoring cell death in the eye.
Career Highlights
Frederick Fitzke is associated with UCL Business Plc, where he continues to contribute to innovative research and development. His work has implications for both scientific understanding and potential therapeutic applications.
Collaborations
Frederick has collaborated with esteemed colleagues such as Francesca Cordeiro and Stephen Moss. These partnerships enhance the impact of his research and foster a collaborative environment for innovation.
Conclusion
Frederick Fitzke's contributions to the field of biomedical research, particularly through his patent on cell death markers, highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve health outcomes in eye care.